Estrogen pill vs. patch for Turner syndrome
Part of Genetic & congenital, Heart & circulation, Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial compares oral and transdermal (patch) estrogen to find the right dose for women with Turner syndrome. It aims to see which method works best for hormone replacement.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a diagnosis of Turner syndrome (any type).
- You must be between 18 and 50 years old.
- You must currently be taking estrogen therapy.
- You cannot have serious ongoing health conditions (like cancer, liver disease, or blood clots).
- You cannot be pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways of taking estrogen (pills or a skin patch) in women with Turner syndrome to see which works better over time. It also includes healthy women for comparison.
This study tests a low-dose estrogen patch for girls with Turner syndrome. It aims to help with growth and development during childhood. The treatment is given before puberty.
This trial compares different hormone treatments to help start puberty in girls and young women with Turner syndrome who have not yet begun puberty. It aims to find the best approach to promote breast development and uterus growth.
This study looks at how different ways of taking progesterone (a hormone given along with estrogen) affect bleeding patterns in teens with Turner syndrome. The goal is to find the best hormone schedule to cause regular, predictable periods.
This study compares two ways to give progesterone to young people on estrogen replacement therapy to see how they affect the lining of the uterus. It will help find which approach may be safer and more effective for your health.
This study looks at how estrogen therapy affects heart health in women with primary ovarian insufficiency (early menopause). Participants will take a standard estrogen patch and progesterone pill, and researchers will monitor their heart function over time.
Hear when a new Turner Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.